Natalia Martin Orozco

Company: Providence Therapeutics Inc.

Job title: Chief Scientific Officer

Seminars:

Reviewing the Role of Lipid Nanoparticles in Enhancing the Effectiveness of mRNA Cancer Vaccines 10:30 am

Discussing the advancements of using LNP’s for mRNA Cancer vaccines to improve the research in the uptake and processing of the vaccine by the body, leading to a better immune response and greater efficacy Revealing the new techniques that have been developed to reduce the risk of degradation and increase the longevity of LNPs in…Read more

day: Conference Day Two